𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The histochemical evaluation of proliferation in breast carcinomas labelled in vivo with bromodeoxyuridine

✍ Scribed by M. Ashton-Key; I.D. Campbell; D.A. Rew; I. Taylor; R. Stradling; R. Coddington; G.D. Wilson

Book ID
113404241
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
778 KB
Volume
2
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Evaluation of proliferation parameters i
Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers
✍ M. M. F. J. Tinnemans; M.-H. J. H. Lenders; F. C. S. Ramaekers; B. Schutte; G. P πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 775 KB

In a series of 44 bronchial biopsies from patients suspected of having endobronchial lung carcinoma, the validity of proliferating cell nuclear antigen (PCNA) and Ki67 antigen as proliferative indicators was evaluated in ethanol fixed, paraffin embedded tissue. The percentages of cells positive for

High proliferative rates demonstrated by
High proliferative rates demonstrated by bromodeoxyuridine labeling index in breast carcinomas with p53 overexpression
✍ John S. Meyer; Weihua He πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 673 KB

The protein p53 is a product of a suppressor oncogene. Mutations occurring in 13-15% of breast carcinomas are associated with p53 stainability within nuclei and progression of the tumor. We determined the extent to which p53 abnormality was associated with proliferation by measuring p53 immunohistoc